HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Sánchez-Ramón Selected Research

typhoid Vi polysaccharide vaccine (Typhim Vi)

1/2020Evaluation of Polysaccharide Typhim Vi Antibody Response as a predictor of Humoral Immunodeficiency in Haematological Malignancies.
1/2020Typhim vi immunization assists to discriminate primary antibody responses in hematological malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Sánchez-Ramón Research Topics

Disease

3Infections
01/2020 - 12/2000
2Atopic Dermatitis (Atopic Eczema)
01/2013 - 09/2012
2Necrosis
01/2006 - 12/2000
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
07/2005 - 03/2001
2Acquired Immunodeficiency Syndrome (AIDS)
02/2002 - 04/2001
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Neoplasms (Cancer)
01/2020
1Communicable Diseases (Infectious Diseases)
11/2018
1Virus Diseases (Viral Diseases)
11/2018
1Lung Diseases (Lung Disease)
11/2017
1Neuromyelitis Optica (Devic's Disease)
06/2015
1Inflammation (Inflammations)
01/2013
1Asthma (Bronchial Asthma)
09/2012
1Skin Diseases (Skin Disease)
09/2012
1Respiratory Tract Infections (Respiratory Tract Infection)
04/2011
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2006
1Nephritis
01/2006
1Lupus Nephritis
01/2006
1Sjogren's Syndrome (Sjogren Syndrome)
06/2005
1Thyroid Diseases (Thyroid Disease)
05/2003
1Heart Diseases (Heart Disease)
11/2001
1Diabetes Mellitus
11/2001
1Hyperlipidemias (Hyperlipidemia)
11/2001
1Hypertension (High Blood Pressure)
11/2001
1Disease Progression
04/2001
1HIV Infections (HIV Infection)
04/2001
1Thrombosis (Thrombus)
03/2001

Drug/Important Bio-Agent (IBA)

4AntibodiesIBA
06/2015 - 05/2003
3AntigensIBA
01/2020 - 04/2011
2Polysaccharides (Glycans)IBA
01/2020 - 01/2020
2Immunoglobulins (Immunoglobulin)IBA
01/2020 - 06/2015
2typhoid Vi polysaccharide vaccine (Typhim Vi)FDA Link
01/2020 - 01/2020
2Pharmaceutical PreparationsIBA
11/2017 - 09/2012
2Immunoglobulin G (IgG)IBA
06/2015 - 06/2005
2Rituximab (Mabthera)FDA Link
06/2015 - 01/2013
2Omalizumab (Xolair)FDA Link
01/2013 - 09/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006 - 12/2000
2Anticardiolipin AntibodiesIBA
07/2005 - 03/2001
2Antiphospholipid AntibodiesIBA
11/2001 - 03/2001
2Retinaldehyde (Retinal)IBA
11/2001 - 03/2001
1Biomarkers (Surrogate Marker)IBA
11/2018
1ProgesteroneFDA LinkGeneric
12/2013
1Estradiol (Delestrogen)FDA LinkGeneric
12/2013
1Hormones (Hormone)IBA
12/2013
1AutoantibodiesIBA
01/2013
1anti-IgE antibodiesIBA
09/2012
1Etanercept (Enbrel)FDA Link
01/2006
1Cardiolipins (Cardiolipin)IBA
07/2005
1fodrinIBA
06/2005
1anti-thyroglobulinIBA
05/2003
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
05/2003
1Thyroxine (Levothyroxine)FDA LinkGeneric
05/2003
1Interleukin-5 (Interleukin 5)IBA
04/2001
1InterleukinsIBA
12/2000
1CytokinesIBA
12/2000

Therapy/Procedure

6Therapeutics
01/2020 - 12/2000
1Plasmapheresis
01/2006
1Highly Active Antiretroviral Therapy (HAART)
02/2002